Sarah Romano - Oct 4, 2023 Form 4 Insider Report for First Wave BioPharma, Inc. (FWBI)

Signature
/s/ Sarah Romano
Stock symbol
FWBI
Transactions as of
Oct 4, 2023
Transactions value $
-$486
Form type
4
Date filed
10/6/2023, 04:05 PM
Previous filing
Jul 5, 2023
Next filing
Jan 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FWBI Common Stock Sale -$486 -1.68K -9.59% $0.29 15.8K Oct 4, 2023 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.291 to $0.293. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 Includes unvested RSUs.